InterCure (NASDAQ:INCR) versus Jushi (OTCMKTS:JUSHF) Financial Survey

InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Analyst Ratings

This is a summary of recent recommendations and price targets for InterCure and Jushi, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	1	0	0	0	1.00
Jushi	0	0	0	1	4.00

Institutional and Insider Ownership

8.3% of InterCure shares are held by institutional investors. Comparatively, 21.7% of Jushi shares are held by institutional investors. 21.7% of Jushi shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares InterCure and Jushi’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
Jushi	-25.15%	N/A	-15.07%

Risk and Volatility

InterCure has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Jushi has a beta of -0.85, meaning that its stock price is 185% less volatile than the S&P 500.

Earnings & Valuation

This table compares InterCure and Jushi”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$64.55 million	N/A	-$18.32 million	$0.13	9.85
Jushi	$257.52 million	0.35	-$48.78 million	($0.33)	-1.37

InterCure has higher earnings, but lower revenue than Jushi. Jushi is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Summary

InterCure beats Jushi on 6 of the 11 factors compared between the two stocks.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.